Now also a stock exchange traded everyday life from the view of a gynecologist.
When I get up in the morning, I first take my Dreamlens from MPG&E out of my eyes. These are hard contact lenses that you have to wear at night and then during the day WITHOUT ANYTHING have a visual acuity of 110% (in my case). I usually have minus 5.5 - and glasses and mask - you know the fuss. Unfortunately, I have found no share at all, but still did not want to withhold MY discovery of 2021.
But now really further... with my $MBG (-1,11%) V-Class I drive half an hour to the MVZ practice in Berlin-Lichtenberg.
Arrived there my consultation nurse already has the $DELL PC and my bluetooth $LOGN (+0,17%) Keyboard + mouse up.
My ultrasound machine is leased from $SMSD (-0,14%) Samsung and makes really good pictures. I love ultrasound almost as much as laparoscopy, but since currently only the former is possible in the outpatient area, I greet my sono every morning with a hug.
My gynecological chair and colposcope manufacturers (the lamp for the gynecological examination) have unfortunately not yet made it to the stock market; but I have a sharp view thanks to the table microscope from the good Carl Zeiß. $AFX. (-0,37%)
To get results from the examination, smear systems are needed. One of them is the "ThinPrep" a fine rubber brush, manufactured by Hologic $HOLX (-0,72%) and is said to be particularly good at finding precancerous lesions.
Then it's on to the medications, because you have to deal with the pharmaceutical industry here, the range of contraceptives alone is almost endless, closely followed by the little helpers in the menopause.
The Gardasil vaccine against cervical cancer is manufactured by Sanofi-Pasteur. $SAN (+0,55%) manufactured. If I have a choice in creams and tinctures, I like to use German manufacturers like e.g. $BAYN (-0,89%) (Bayer / Jenapharm) and I often tell the patients that there is not ALWAYS something from Ratiopharm $TEVA (+1,42%) and that many complaints should first be tackled with lifestyle changes.
That's it for now - thanks for the attention!
